| Application no. and date | 12863862.4 (espacenet) (Federated) (European Patent Register), 20121228 | | Patent/reg. no. and date | DK/EP 2797615, 20190403 | | Publication date | 20141105 | | Priority no. and date | US 201161581391 P, 20111229 | | EP pub. no. and date |
EP 2797615 20141105 | | Effective date | | | Applicant/owner | Rhythm Pharmaceuticals, Inc., 222 Berkeley Street, 12th floor
Boston, MA 02116 , US | | Applicant ref. no. | P81902637DK00E | | Inventor | TARTAGLIA, Louis, A., 32 Manor House Road
Newton, MA 02459, US,
HENDERSON, Bart, 48 Prentiss Lane
Belmont, MA 02478, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 38/04 (2006.01) , A61K 38/08 (2019.01) , C07K 14/72 (2006.01) | | Title | Fremgangsmåde til behandling af melanocortin-4-receptor-associerede forstyrrelser hos heterozygotiske bærere | | Int. application no. | US2012072026 | | Int. publication no. | WO2013102047 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
